Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 23, 2019

SELL
$16.51 - $23.78 $4.38 Million - $6.31 Million
-265,459 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$22.06 - $25.52 $882,400 - $1.02 Million
40,000 Added 17.74%
265,459 $6.02 Million
Q4 2017

Feb 06, 2018

BUY
$25.82 - $35.66 $1.68 Million - $2.32 Million
65,000 Added 40.51%
225,459 $6.29 Million
Q3 2017

Oct 25, 2017

BUY
$23.88 - $34.96 $3.83 Million - $5.61 Million
160,459
160,459 $5.49 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $640M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.